Proteome Sciences Plc (PRM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Proteome Sciences Plc (PRM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7043
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expressions and modifications that help define processes for improving research outcomes. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer’s, Huntington’s, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in London, England, the UK.

Proteome Sciences Plc (PRM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Proteome Sciences Plc, Medical Equipment, Deal Details 10
Partnerships 10
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Equity Offering 13
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 13
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 14
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 15
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 16
Proteome Sciences Plc – Key Competitors 17
Proteome Sciences Plc – Key Employees 18
Proteome Sciences Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Jul 24, 2018: Proteome Sciences: Interim results for the six months ended 30 June 2018 21
Apr 24, 2018: Proteome Sciences: Preliminary results for the year ended 31 December 2017 24
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 29
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 30
Corporate Communications 41
Apr 24, 2018: Proteome Sciences Appoints Richard Dennis As Board Director 41
Aug 01, 2017: Proteome Sciences: Directorate changes 42
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 43
Legal and Regulatory 44
Oct 18, 2017: Proteome Sciences: GCLP Accreditation and Trading Update 44
Jun 12, 2017: Proteome Sciences: New Registered Address 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Proteome Sciences Plc, Medical Equipment, Key Facts, 2017 2
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Deals By Market, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 13
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 14
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 15
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 16
Proteome Sciences Plc, Key Competitors 17
Proteome Sciences Plc, Key Employees 18
Proteome Sciences Plc, Other Locations 19
Proteome Sciences Plc, Subsidiaries 19

List of Figures
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Proteome Sciences Plc (PRM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anthem Inc (ANTM)-製薬・医療分野:企業M&A・提携分析
    Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life an …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AB SKF (SKF B):企業の財務・戦略的SWOT分析
    AB SKF (SKF B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Regulus Therapeutics Inc (RGLS):医療機器:M&Aディール及び事業提携情報
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Rich Products Corporation:企業の戦略・SWOT・財務情報
    Rich Products Corporation - Strategy, SWOT and Corporate Finance Report Summary Rich Products Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Banco Cooperativo Espanol S.A.:企業の戦略・SWOT・財務分析
    Banco Cooperativo Espanol S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco Cooperativo Espanol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. The company manufactures and markets high performance polymers and specialty chemicals. Its products include bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie …
  • 3E sanv:企業の戦略的SWOT分析
    3E sanv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • NTT DATA Corporation (9613):企業の財務・戦略的SWOT分析
    NTT DATA Corporation (9613) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報
    Summary Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen t …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • BayWa AG:戦略・SWOT・企業財務分析
    BayWa AG - Strategy, SWOT and Corporate Finance Report Summary BayWa AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Mashreqbank psc:企業の戦略・SWOT・財務情報
    Mashreqbank psc - Strategy, SWOT and Corporate Finance Report Summary Mashreqbank psc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Nickel Asia Corporation:企業の戦略・SWOT・財務情報
    Nickel Asia Corporation - Strategy, SWOT and Corporate Finance Report Summary Nickel Asia Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Provenance Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Provenance Biopharmaceuticals Corp (Provenance) is a biotechnology company that develops various novel immunotherapeutic drugs to treat cancer and other serious, life-threatening diseases. The company offers cancer drugs based on antibodies which include avastin, erbitux, hercepton, and ritu …
  • Northam Platinum Limited:企業の戦略・SWOT・財務分析
    Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aspect Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aspect Imaging Inc (Aspect Imaging) is a medical device company that develops and manufactures magnetic resonance imaging systems. The company’s products comprise wristview medical systems, preclinical, process control, oil and gas analyzers, NMR, materials MRI and software. It offers precli …
  • Cellmid Ltd (CDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Duke Energy Indiana LLC:企業の戦略的SWOT分析
    Duke Energy Indiana LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆